Prelude Therapeutics
PRLD
#9260
Rank
HK$0.41 B
Marketcap
HK$7.53
Share price
0.57%
Change (1 day)
-70.10%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -HK$17.00

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$16.89. In 2022 the company made an earnings per share (EPS) of -HK$18.99 a decrease over its 2021 EPS that were of -HK$18.84.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$17.00-10.5%
2022-HK$18.990.83%
2021-HK$18.84-61.3%
2020-HK$48.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.97 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA